Prioritization and organ distribution for liver transplantation.
作者信息
Bronsther O, Fung J J, Izakis A, Van Thiel D, Starzl T E
机构信息
Pittsburgh Transplant Institute, University of Pittsburgh (Pa) Medical Center.
出版信息
JAMA. 1994 Jan 12;271(2):140-3.
Abstract
摘要
相似文献
1
Prioritization and organ distribution for liver transplantation.肝移植的优先级确定与器官分配
JAMA. 1994 Jan 12;271(2):140-3.
2
The ethics of competition in liver transplantation.肝移植中的竞争伦理
Camb Q Healthc Ethics. 1999 Summer;8(3):321-9. doi: 10.1017/s0963180199803077.
3
Controversial aspects of the current liver donor allocation system for liver transplantation.当前肝移植肝脏供体分配系统的争议性方面。
Acad Radiol. 1995 Mar;2(3):244-8. doi: 10.1016/s1076-6332(05)80173-4.
4
A critique of UNOS liver allocation policy. United Network for Organ Sharing.对器官共享联合网络（UNOS）肝脏分配政策的批评。器官共享联合网络。
Camb Q Healthc Ethics. 1999 Summer;8(3):311-20. doi: 10.1017/s0963180199803065.
5
The high-risk liver allograft recipient. Should allocation policy consider outcome?高风险肝移植受者。分配政策应考虑结果吗？
Arch Surg. 1992 May;127(5):579-84. doi: 10.1001/archsurg.1992.01420050103013.
6
MELD and PELD: application of survival models to liver allocation.终末期肝病模型（MELD）和小儿终末期肝病模型（PELD）：生存模型在肝脏分配中的应用
Liver Transpl. 2001 Jul;7(7):567-80. doi: 10.1053/jlts.2001.25879.
7
Geographic favoritism in liver transplantation--unfortunate or unfair?肝移植中的地域偏袒——是不幸还是不公？
N Engl J Med. 1998 Oct 29;339(18):1322-5. doi: 10.1056/NEJM199810293391811.
8
Organ transplant allocation.器官移植分配
Kennedy Inst Ethics J. 1995 Dec;5(4):365-84. doi: 10.1353/ken.0.0117.
9
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?原发性胆汁性肝硬化和原发性硬化性胆管炎的肝移植：药物治疗会改变时机和选择吗？
Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S9-17.
10
The balance of risk score for allocation in liver transplantation.肝移植分配中风险评分的平衡
Ann Surg. 2014 Feb;259(2):e34. doi: 10.1097/SLA.0b013e3182a18086.
引用本文的文献
1
A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis.一种用于预测原发性硬化性胆管炎患者肝移植后个体生存的新型学习算法。
PLoS One. 2018 Mar 15;13(3):e0193523. doi: 10.1371/journal.pone.0193523. eCollection 2018.
2
Is SAPS 3 better than APACHE II at predicting mortality in critically ill transplant patients?SAPS 3 预测危重症移植患者死亡率是否优于 APACHE II？
Clinics (Sao Paulo). 2013;68(2):153-8. doi: 10.6061/clinics/2013(02)oa06.
3
Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model.良性终末期肝病肝移植受者移植后生存的移植前预测：一种非线性模型。
PLoS One. 2012;7(3):e31256. doi: 10.1371/journal.pone.0031256. Epub 2012 Mar 1.
4
Geographic inequity in access to livers for transplantation.器官移植中肝脏获取的地理不公平性。
Transplantation. 2011 Feb 27;91(4):479-86. doi: 10.1097/TP.0b013e3182066275.
5
Complications of right lobe living donor liver transplantation.右叶活体供肝肝移植的并发症
J Hepatol. 2009 Oct;51(4):715-24. doi: 10.1016/j.jhep.2009.04.023. Epub 2009 May 27.
6
Pretransplant model to predict posttransplant survival in liver transplant patients.预测肝移植患者移植后生存率的移植前模型。
Ann Surg. 2002 Sep;236(3):315-22; discussion 322-3. doi: 10.1097/00000658-200209000-00008.
7
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.高危患者的原位肝移植：与死亡率和感染性发病率相关的危险因素
Transplantation. 1998 Feb 27;65(4):499-504. doi: 10.1097/00007890-199802270-00008.
8
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.评估肝移植中的风险。特别提及阳性细胞毒性交叉配型的意义。
Ann Surg. 1996 Aug;224(2):168-77. doi: 10.1097/00000658-199608000-00009.
9
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation.接受肝移植的退伍军人中，原发性门静脉血栓形成的发生率较高。
J Surg Res. 1996 Feb 1;60(2):333-8. doi: 10.1006/jsre.1996.0053.
10
Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?原位肝移植术后成人的早期死亡或再次移植。结局能否预测？
Transplantation. 1994 Apr 15;57(7):1028-36. doi: 10.1097/00007890-199404150-00008.
本文引用的文献
1
Racial equity in renal transplantation. The disparate impact of HLA-based allocation.肾移植中的种族公平。基于人类白细胞抗原（HLA）分配的不同影响。
JAMA. 1993 Sep 15;270(11):1352-6.
2
Liver transplant candidate stratification systems. Implications for third-party payors and organ allocation.肝移植候选者分层系统。对第三方支付者和器官分配的影响。
Transplantation. 1994 Jan;57(2):306-8.
3
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.肝移植治疗原发性硬化性胆管炎患者的疗效
Surg Gynecol Obstet. 1993 Oct;177(4):335-44.
4
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.他克莫司：自身免疫性慢性活动性肝炎的一种潜在新疗法：一项开放标签初步试验的结果
Am J Gastroenterol. 1995 May;90(5):771-6.
5
Evolution of liver transplantation.肝移植的发展历程。
Hepatology. 1982 Sep-Oct;2(5):614-36. doi: 10.1002/hep.1840020516.
6
National Institutes of Health Consensus Development Conference on Liver Transplantation. Sponsored by the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases and the National Institutes of Health Office of Medical Applications of Research.美国国立卫生研究院肝脏移植共识发展会议。由国立关节炎、糖尿病、消化和肾脏疾病研究所以及国立卫生研究院医学应用研究办公室主办。
Hepatology. 1984 Jan-Feb;4(1 Suppl):1S-110S.
7
Equitable allocation of extrarenal organs: with special reference to the liver.肾外器官的公平分配：特别提及肝脏
Transplant Proc. 1988 Feb;20(1):131-8.
8
Extended preservation of the liver for clinical transplantation.用于临床移植的肝脏的延长保存
Lancet. 1988 Mar 19;1(8586):617-9. doi: 10.1016/s0140-6736(88)91416-x.
9
Prognosis in primary biliary cirrhosis: model for decision making.原发性胆汁性肝硬化的预后：决策模型
Hepatology. 1989 Jul;10(1):1-7. doi: 10.1002/hep.1840100102.
10
Efficacy of liver transplantation in patients with primary biliary cirrhosis.肝移植治疗原发性胆汁性肝硬化患者的疗效
N Engl J Med. 1989 Jun 29;320(26):1709-13. doi: 10.1056/NEJM198906293202602.
Zotero 插件